STEALTH BIOTHERAPEUTICS CORP's ticker is MITO and the CUSIP is 85789A105. A total of 6 filers reported holding STEALTH BIOTHERAPEUTICS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 487 | -98.3% | 0.00% | – |
| Q2 2022 | $7,000 | +600.0% | 28,519 | +1706.1% | 0.00% | – |
| Q1 2022 | $1,000 | – | 1,579 | +224.2% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 487 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -95.8% | 487 | -96.8% | 0.00% | – |
| Q2 2021 | $24,000 | +200.0% | 15,307 | +220.9% | 0.00% | – |
| Q1 2021 | $8,000 | +700.0% | 4,770 | +594.3% | 0.00% | – |
| Q4 2020 | $1,000 | -90.9% | 687 | -91.2% | 0.00% | – |
| Q3 2020 | $11,000 | -59.3% | 7,802 | -48.0% | 0.00% | – |
| Q2 2020 | $27,000 | +2600.0% | 15,000 | +3650.0% | 0.00% | – |
| Q1 2020 | $1,000 | -95.7% | 400 | -94.3% | 0.00% | – |
| Q4 2019 | $23,000 | -42.5% | 7,000 | +4.3% | 0.00% | – |
| Q3 2019 | $40,000 | +53.8% | 6,714 | +222.6% | 0.00% | – |
| Q2 2019 | $26,000 | +2500.0% | 2,081 | +3101.5% | 0.00% | – |
| Q1 2019 | $1,000 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 501,836 | $127,000 | 0.02% |
| Urban Wealth Management, LLC | 2,939 | $1,000 | 0.00% |
| Virtu Financial LLC | 100,291 | $25,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 48,791 | $12,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 41,517 | $10,000 | 0.00% |
| AlphaMark Advisors, LLC | 2,306 | $1,000 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 17,844 | $5,000 | 0.00% |
| Citadel Advisors | 141,226 | $36,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 54,174 | $14,000 | 0.00% |